RR

Rob Readnour

Director at Advanced Animal Diagnostics

Nashville, Tennessee

Overview 

Rob Readnour is the Managing Director at Mountain Group Partners in Nashville, Tennessee, with a background in analytical chemistry, FDA regulations, drug development, and commercialization. Highlights of his career include serving as Chief Scientific Officer at Elanco Animal Health and investing in companies like Verility and Advanced Animal Diagnostics at various stages of funding.

Work Experience 

  • Managing Director

    2018 - Current

Mountain Group Partners is an investor dedicated to investing in and actively guiding transformation businesses in the Life Science.

  • Director

    2021

Advanced Animal Diagnostics develops diagnostic products to cure on-farm animal diseases.

Raised $50,466,347.00 from LabCorp Venture Fund, Murphy Family Ventures, Alexandria Venture Investments, Mountain Group Capital and Intersouth Partners.

  • Director

    2019

TARGAN is a bio-systems company focused on improving animal health and productivity in the poultry, livestock, and aquaculture industries.

Raised $51,634,999.00 from Mountain Group Capital, Oval Park Capital, Merck Animal Health Ventures and Novaquest Capital Management.

  • Senior Advisor and Chief Scientific Officer - Elanco Alternative Innovation

    2017 - 2018

Elanco develops, manufactures and markets products for companion and food animals.

Raised $252,860,000.00 from Ancora.

  • Senior Director of Product Development, Elanco Animal Health

    1990 - 2017

    Dr. Readnour has led a transformation of Research and Development through the piloting of new approaches to developing animal health drugs, vaccines, enzymes, and diagnostics through virtual product development networks, novel team structures, and alternative funding mechanisms.

Eli Lilly engages in the discovery, development, manufacture, and sale of pharmaceutical products.

Raised $6,500,000.00.

Articles About Rob

Relevant Websites